 |
|
High-Dose Statins in Acute Coronary Syndromes—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: We agree with Dr Crouse that differences in study design and in the LDL-C levels between patients receiving treatment and those not receiving treatment in the A to Z trial and the PROVE IT trial may have contributed to differences in outcomes between the 2 studies. Because cholesterol-lowering studies typically enroll patients with variable cholesterol levels at entry and then treat patients with fixed dosages of study drug, they are not well-suited to identify specific LDL-C level treatment goals. On the other hand, the A to Z trial and the PROVE IT trial do suggest that more aggressive LDL-C level lowering strategies reduce intermediate (2-year) adverse event rates in patients with ACS and support, albeit indirectly, an LDL-C level treatment goal substantially below 100 mg/dL (<2.59 mmol/L). Further studies are needed before a specific LDL-C treatment goal of 70 mg/dL (1.81 mmol/L) can be firmly established. Finally, no . . . [Full Text of this Article]
James A. de Lemos, MD
james.delemos@utsouthwestern.edu
University of Texas Southwestern Medical Center
Dallas
Michael A. Blazing, MD;
Robert M. Califf, MD
Duke Clinical Research Institute
Durham, NC
Stephen D. Wiviott, MD;
Eugene Braunwald, MD
Brigham and Women’s Hospital
Boston, Mass
RELATED LETTER
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial
James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott, Eldrin F. Lewis, Keith A. A. Fox, Harvey D. White, Jean-Lucien Rouleau, Terje R. Pedersen, Laura H. Gardner, Robin Mukherjee, Karen E. Ramsey, Joanne Palmisano, David W. Bilheimer, Marc A. Pfeffer, Robert M. Califf, Eugene Braunwald, and for the A to Z Investigators
JAMA. 2004;292(11):1307-1316.
ABSTRACT
| FULL TEXT
RELATED ARTICLES
High-Dose Statins in Acute Coronary Syndromes
John R. Crouse, III
JAMA. 2005;293(1):36.
EXTRACT
| FULL TEXT
High-Dose Statins in Acute Coronary Syndromes
Bruce Ovbiagele
JAMA. 2005;293(1):36-37.
EXTRACT
| FULL TEXT
High-Dose Statins in Acute Coronary Syndromes
Yale B. Mitchel
JAMA. 2005;293(1):37.
EXTRACT
| FULL TEXT
High-Dose Statins in Acute Coronary Syndromes
William L. Isley
JAMA. 2005;293(1):37-38.
EXTRACT
| FULL TEXT
High-Dose Statins in Acute Coronary Syndromes
Michael H. Davidson
JAMA. 2005;293(1):38.
EXTRACT
| FULL TEXT
High-Dose Statins in Acute Coronary Syndromes—Reply
Steven E. Nissen
JAMA. 2005;293(1):39.
EXTRACT
| FULL TEXT
|
